Search results for "pharmacy"

showing 10 items of 705 documents

Changes in Treatment of Very Elderly Patients Six Weeks after Discharge from Geriatrics Department

2020

We assessed the prescriptions of patients hospitalized in a geriatric unit and subsequently discharged. This prospective and observational study was conducted over a two-month period in the geriatrics department (acute and rehabilitation units) of a university hospital. Patients discharged from this department were included over a two-month period. Prescriptions were analyzed at admission and discharge from the geriatrics department (DGD), and six weeks after DGD. We included 209 patients, 63% female, aged 86.8 years. The mean number of medications prescribed was significantly higher at DGD than at admission (7.8 vs. 7.1, p = 0.003). During hospitalization, 1217 prescriptions were changed (…

Agingmedicine.medical_specialtyHealth (social science)Multivariate analysismedicine.medical_treatmentcare continuitytherapeutic optimizationlcsh:GeriatricselderlyArticle03 medical and health sciences0302 clinical medicineInternal medicineMedicine030212 general & internal medicineMedical prescriptionpolypharmacyGeriatricsPolypharmacyUnivariate analysisRehabilitationbusiness.industryAfter dischargehumanitieslcsh:RC952-954.6Observational studysense organsGeriatrics and GerontologybusinessGerontology030217 neurology & neurosurgeryGeriatrics
researchProduct

GABAA agonist muscimol ameliorates learning/memory deficits in streptozocin-induced Alzheimer’s disease non-transgenic rat model

2015

Background: GABAergic inhibitory action regulates learning/memory processes and contributes to neurotransmission (Gong et al., 2009). Existing evidence suggests GABAergic system is involved in pathophysiology of Alzheimer’s disease (AD) via inhibitory interneuron deficits (Verret et al., 2012) and decrease in functional GABAA receptors (Limon et al., 2012). In vitro, GABA and muscimol (GABAA receptor agonist) blocked neuronal death induced by Aβ in rat hippocampal and cortical neurons (Paula-Lima et al., 2005). Our concept: low doses of muscimol may prevent learning/memory deficits in intracerebroventricular (icv) streptozocin (STZ)-induced AD non-transgenic rat model. Methods. Wistar male …

Agonistmedicine.medical_specialtymedicine.drug_class02 engineering and technologyWater mazeNeurotransmissionHippocampal formationInhibitory postsynaptic potential030226 pharmacology & pharmacymemory03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineMedicineMultidisciplinarybusiness.industryGABAA receptorstreptozocin021001 nanoscience & nanotechnologymuscimol3. Good healthEndocrinologynervous systemMuscimolchemistryAnesthesiaPoster PresentationGABAergic0210 nano-technologybusinessSpringerPlus
researchProduct

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

2018

mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), th…

AllergyHEALTH-ORGANIZATIONIMPACTRespiratory Medicine and Allergy[SDV]Life Sciences [q-bio]Allergic Rhinitis and its Impact on Asthma - ARIAReviewMASK - Mobile Airways Sentinel networK0302 clinical medicine610 Medical sciences MedicineApp; ARIA; Asthma; Care pathways; MASK; mHealth; Rhinitis; Immunology and Allergy; Immunology; Pulmonary and Respiratory MedicineHealth careMedicine and Health SciencesImmunology and Allergy030212 general & internal medicineAndroid (operating system)mHealthRinitisRhinitiComputingMilieux_MISCELLANEOUSLungmedicin och allergiRhinitisPRODUCTIVITY3. Good healthALLERGIC RHINITISmHealthRiniteCare pathwaysMedical emergencyLife Sciences & BiomedicinePulmonary and Respiratory MedicineSTRATEGIESMASKMASK study groupImmunologyMEDLINE610K-ANONYMITYPharmacy[object Object]Settore MED/10 - Malattie Dell'Apparato RespiratorioVALIDATIONMACVIA-ARIA03 medical and health sciencesmedicineMobile technologyTECHNOLOGYApp -MASKApp ; ARIA ; Asthma ; Care pathways ; MASK ; mHealth ; RhinitisARIA; App; Asthma; Care pathways; MASK; Rhinitis; mHealthAsmaAsthmaCare pathwayScience & TechnologyARIAbusiness.industryApp; ARIA; Asthma; Care pathways; MASK; mHealth; RhinitisSettore MED/09 - MEDICINA INTERNACorrectionGuidelineRC581-607medicine.diseaseAsthma030228 respiratory systemImmunologic diseases. AllergybusinessAppEUROPEAN COUNTRIES[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Risque phytosanitaire (ARP) portant sur Fusarium oxysporum f. sp. cubense (agent pathogène responsable de la maladie de Panama) pour les départements…

2018

Risque phytosanitaire (ARP) portant sur [i]Fusarium oxysporum[/i] f. sp.[u] cubense[/u] (agent pathogène responsable de la maladie de Panama) pour les départements d'Outre-mer

Analyse de risque phytosanitaire[SDV.SA]Life Sciences [q-bio]/Agricultural sciences[SDV.SA] Life Sciences [q-bio]/Agricultural sciencesoutre mer françaisétat de l'artrisque économiqueregulationweed control methodsrace tropicale 4champignon phytopathogèneexpertise scientifiquephytopathogenic fungusbananedétection[SDV.BV.PEP]Life Sciences [q-bio]/Vegetal Biology/Phytopathology and phytopharmacyFoc TR4méthode de luttemaladie de PanamaFusarium oxysporum f. sp. cubenseréglementationpathologie végétale[SDV.BV.PEP] Life Sciences [q-bio]/Vegetal Biology/Phytopathology and phytopharmacyéconomie des filières
researchProduct

Micellar liquid chromatography determination of rivaroxaban in plasma and urine. Validation and theoretical aspects.

2019

A Micellar Chromatographic method to determine rivaroxaban in plasma and urine has been developed. The samples were dissolved in the mobile phase (SDS 0.05 M – 1-propanol 12.5%, phosphate buffered at pH 7) and 20 μL directly injected, avoiding the extraction and purification steps. Using a C18 column and running under isocratic mode at 1 mL/min, analyte was eluted without interference from the matrix in <6.0 min. The detection absorbance wavelength was set to 250 nm. The procedure was validated by Food and Drug Administration guidelines in terms of: system suitability, calibration range (0.05–5 mg/L), linearity, sensitivity, robustness, carry-over effect, specificity, accuracy (−11.1 to 4.2…

AnalyteClinical Biochemistrypartition equilibriumUrine030226 pharmacology & pharmacy01 natural sciencesBiochemistryAnalytical Chemistrymicellar chromatographyMatrix (chemical analysis)03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRivaroxabanLimit of Detectiondirect injectionHumansMicellesvalidationChromatographyElutionanticoagulant010401 analytical chemistryExtraction (chemistry)biological fluidReproducibility of ResultsCell BiologyGeneral MedicinePhosphate0104 chemical scienceschemistryMicellar liquid chromatographyPartition equilibriumLinear ModelsChromatography LiquidJournal of chromatography. B, Analytical technologies in the biomedical and life sciences
researchProduct

Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways …

2018

A semi-physiological two compartment pharmacokinetic model with two active metabolites (primary (PM) and secondary metabolites (SM)) with saturable and non-saturable pre-systemic efflux transporter, intestinal and hepatic metabolism has been developed. The aim of this work is to explore in several scenarios which analyte (parent drug or any of the metabolites) is the most sensitive to changes in drug product performance (i.e. differences in in vivo dissolution) and to make recommendations based on the simulations outcome. A total of 128 scenarios (2 Biopharmaceutics Classification System (BCS) drug types, 2 levels of KM Pgp, in 4 metabolic scenarios at 2 dose levels in 4 quality levels of t…

AnalyteCmaxPharmaceutical ScienceAdministration Oral02 engineering and technologyEquivalence Trials as TopicPharmacologyBioequivalence030226 pharmacology & pharmacyModels Biological03 medical and health sciencesFirst pass effect0302 clinical medicinePharmacokineticsHumansComputer SimulationPharmacokineticsIntestinal MucosaBiotransformationChemistryMembrane Transport Proteins021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemNONMEMNonlinear DynamicsPharmaceutical PreparationsSolubilityTherapeutic EquivalencyResearch DesignArea Under CurveLinear Models0210 nano-technologyMonte Carlo MethodDrug metabolismEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Relationship between particle size and dissolution rate of bulk powders and sieving characterized fractions of two qualities of orthoboric acid

1996

Drug Dev. Ind. Pharm. ISI Document Delivery No.: VN279 Times Cited: 1 Cited Reference Count: 22 Tromelin, A Habillon, S Andres, C Pourcelot, Y Chaillot, B; International audience; We have carried out a study of the particle size distribution and aqueous dissolution rate of two commercially available qualities of orthoboric acid, labeled ''crystal'' (ABC) and ''powder'' (ABP). In a previous work, we have shown that the two commercial qualities of orthoboric acid chosen as model compound (''powder'' and ''crystal'') are related to the same crystal network in spite of their different names. However, these two qualities have very different size particle distributions, as previously determined b…

Analytical chemistryPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyrelease03 medical and health sciences0302 clinical medicine[CHIM.ANAL]Chemical Sciences/Analytical chemistryDrug DiscoverymorphologySize fractionsDissolution testingdissolution rateDissolutionfractal geometryPharmacologyAqueous solutionChemistryOrganic Chemistryparticle size021001 nanoscience & nanotechnologyLaser light scattering[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistryCrystallography[SDV.SP.PG]Life Sciences [q-bio]/Pharmaceutical sciences/Galenic pharmacologyParticle-size distributionParticle size0210 nano-technology
researchProduct

The Effect of Methanolic Leaf Extract of Boerhavia diffusa Linn. (Nictaginaceae) on the Activities of Antidiabetic, Anti-inflammatory and Antioxidant…

2018

Diabetic therapeutic potentiality of methanol extract of stem leaves of Boerhavia diffusa was investigated following in-vivo study models in streptozotocin-induced diabetic rat. Methanol extract of stem leaves of Boerhavia diffusa exerted the glucose lowering effect an increase in serum insulin level on 28st day of postadministration. In addition to a higher expression of insulin receptor A. The extract treatment or glibenclamide for 28 days significantly (p<0.05) reduced HbA1c. Boerhavia diffusa L. or glibenclamide for 28 days show no damaging effect on red blood count and hemoglobin when compared to the control group.  Significant (p<0.05) increase in platelet count and white blood cell c…

AntioxidantBoerhaviabiologyTriglyceridemedicine.drug_classmedicine.medical_treatmentPharmacologybiology.organism_classificationAscorbic acid030226 pharmacology & pharmacyAnti-inflammatoryGlibenclamideLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistry030220 oncology & carcinogenesismedicineXanthine oxidasemedicine.drugJournal of Pharmaceutical Research International
researchProduct

Enhanced In Situ Availability of Aphanizomenon Flos-Aquae Constituents Entrapped in Buccal Films for the Treatment of Oxidative Stress-Related Oral D…

2019

In recent years, the key role of oxidative stress in pathogenesis of oral diseases has been emphasized and the use of antioxidant agents has been encouraged. Aphanizomenon flos-aquae (AFA) is a unicellular blue-green alga with antioxidant and anti-inflammatory properties. The aim of this study was the formulation and characterization of mucoadhesive thin layer films loaded with AFA, finalized to the treatment of oxidative stress (OS)-related oral diseases. First, to enhance the bioavailability of AFA constituents, the raw food grade material was appropriately treated by a high frequency homogenization able to disrupt cell walls. Thus, Eudragit&reg

Antioxidantbuccal filmmedicine.medical_treatment<i>Aphanizomenon flos-aquae</i>lcsh:RS1-441Pharmaceutical Science02 engineering and technologymedicine.disease_causeArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineparasitic diseasesOS-related oral diseasesmedicineFood scienceEudragit E100Chemistryex vivo permeationBuccal administrationPenetration (firestop)Aphanizomenon flos-aquaePermeation021001 nanoscience & nanotechnologyBioavailabilitySettore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesishigh frequency homogenizationOS-related oral diseasebiomechanical testSwellingmedicine.symptom0210 nano-technologyEx vivoOxidative stressPharmaceutics
researchProduct

L'ergot dépasse le seigle cet ancien compagnon de l'homme ressort les griffes

2010

National audience; L’ergot du seigle dû à Claviceps purpurea se fait remarquer en cultures de céréales en France depuis 2000, sporadiquement et avec une prévalence moindre qu’en Europe du Nord. Le facteur climatique (4 années favorables de 2000 à 2009 incluses) joue sur cette réémergence, mais aussi des évolutions de pratiques culturales : développement du nonlabour et présence accrue de graminées adventices sensibles dans les parcelles ou à proximité. Les connaissances sur la biologie de C. purpurea et les facteurs le favorisant sont rappelées. Le rôle des graminées adventices et prairiales est évoqué avec les sensibilités diverses des espèces, pouvant influencer le choix de celles à impla…

BIOAGRESSEURS RE-EMERGEANTSINSECTEGRAMINEES ADVENTICESERGOT DE SEIGLE CLAVICEPS PURPUREA[SDV.BV.PEP] Life Sciences [q-bio]/Vegetal Biology/Phytopathology and phytopharmacy[SDV.BV.PEP]Life Sciences [q-bio]/Vegetal Biology/Phytopathology and phytopharmacyPOOIDEESPREVALENCE
researchProduct